SCHEMBL7657710

SCHEMBL7657710

NC(=NO)c1ccc(NC(=O)c2ccccc2-c2ccccc2C(=O)O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.66
CYP3A4 P08684 1/20 0.66
ALOX12 P18054 1/20 0.66
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
P4HB P07237 1/20 0.55
ALDH1A1 P00352 2/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
TP53 P04637 1/20 0.53
HPGD P15428 1/20 0.53
LMNA P02545 1/20 0.52
PPARG P37231 1/20 0.51
ATM Q13315 1/20 0.51
TSHR P16473 1/20 0.51
HDAC1 Q13547 2/20 0.50
HDAC2 Q92769 2/20 0.50
F2 P00734 1/20 0.50
F10 P00742 1/20 0.50
PRSS1 P07477 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7656984 0.99 CYP2C9 (0.64) CYP2C9CYP3A4ALOX12MEN1KMT2A
SCHEMBL7657788 0.89 NPC1 (0.53) CYP2C9CYP3A4ALOX12MEN1KMT2A
Hydrochloric Acid SCHEMBL7662470 0.88 NPC1 (0.52) CYP2C9CYP3A4ALOX12MEN1KMT2A
SCHEMBL7661930 0.83 CYP3A4 (0.69) CYP2C9CYP3A4ALOX12MEN1KMT2A
Hydrochloric Acid SCHEMBL7655131 0.82 CYP3A4 (0.68) CYP2C9CYP3A4ALOX12MEN1KMT2A
SCHEMBL7657919 0.82 F3 (0.79) F2F10PRSS1PRSS2F7
SCHEMBL7661471 0.80 CYP3A4 (0.53) CYP2C9CYP3A4ALOX12MEN1KMT2A
SCHEMBL7660125 0.79 CYP2C9 (0.52) CYP2C9CYP3A4ALOX12MEN1KMT2A
SCHEMBL7659362 0.78 CYP2C9 (0.51) CYP2C9CYP3A4ALOX12MEN1KMT2A
SCHEMBL7663108 0.78 F10 (0.64) CYP2C9CYP3A4ALOX12MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US claimed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP claimed